Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.
← All analysis

Costco Wholesale Corporation (COST)

Verdict history · COST

Every call Verdix has made on COST.

While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.

See methodology for how verdicts are produced. Full track record →

Why the panel isn’t ready to call COST yet — and where they disagree.

WaitHIGH confidence

A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.

NASDAQ · Consumer Staples / Retail · 2026-08-15 · analysis, not advice

Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.

Verdict

Wait

HIGH confidence

Why

Costco earns a rare consensus as a world-class business — 92% renewal rates, 38% ROIC, and a fortress balance sheet — but the panel splits sharply on whether 48x trailing earnings leaves any room for acceptable returns. Every voice wants to own it; none is willing to pay today's price, and the real debate is how much of a pullback justifies pulling the trigger.

Level to watch

Key resistance 970.28

+1.0% from 961.1

Next catalyst

Key support to watch: The $933–$940 zone (monthly EMA20 and Fibonacci 23.6% confluence) is the line in the sand: a weekly close below it on elevated volume would confirm Stage 3 and open a path toward $844.

The panel's take

Verdict: WAIT · Conviction: HIGH · Last price: 961.1

All voices agree Costco is a world-class business with a fortress balance sheet, durable moat, and elite returns on capital. The split is pure PRICE/TIMING: the non-Bull camp (The Moat Compounder, The Quality Rationalist, The GARP Operator, The Activist Catalyst) wants to own Costco but not at 48x earnings — they want a lower price, not a different company. Only The Intrinsic-Value Modeler and The Forensic Skeptic are structurally bearish on the stock at this price, and even The Forensic Skeptic calls it "one of the best" businesses. The BUY vs WAIT split is lopsided: zero voices recommend buying now, while the PRICE/TIMING-dominant cautious camp unanimously converges on "wait for a pullback." A specific trigger exists — $920–$940 zone (monthly EMA20 / Fib 23.6%) or a weekly close above $970 for the breakout camp. This is the textbook WAIT structure.

Key levels

Key levels · COST

USD · as of 2026-08-15
Analyst consensus 961.1
R31,096.5
+14.1%
R2981.5
+2.1%
R1970.28
+1.0%
S1940.49
−2.1%
S2933.66
−2.9%
S3844.06
−12.2%
NOW
961.1

Analyst consensus target 961.1 USD · range 961.1961.1

Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.

What legendary investors think

We ran Costco Wholesale Corporation past a panel of 6 legendary investors' frameworks.

The panel · 6 investors

🟢
0
Bullish
4
Neutral
🔴
2
Bearish
The Moat CompounderValue/Quality/Moat NeutralMed

Signal: Costco's 92.2% North American membership renewal rate and 38.4% ROIC confirm a widening moat, but at 48x trailing earnings the earnings yield sits at roughly 2.1% — below the risk-free rate — leaving no margin of safety for new money. Conviction: Conviction is elevated because the fundamental story and the technical picture converge cleanly: the weekly MACD is bearish, price sits below the 20-week EMA, and insiders have been selling with zero buys — three independent signals all pointing toward patience rather than action.

The Quality RationalistMental Models/Quality NeutralMed

Signal: Costco's membership tollbooth and 38% ROIC put it squarely in wonderful-business territory, but with a trailing P/E of 48x — more than double the sector median — you need a decade of 10%+ earnings growth just to earn a reasonable return, and the expected outcome from here is low single digits at best. Conviction: What holds conviction back is the narrow gap between analyst targets and the current price: the average target of $1,077 offers only 12% upside, which is thin compensation for taking on a stock that could correct 20–30% in a cycle.

The GARP OperatorGrowth (GARP) NeutralMed

Signal: Costco is the best-run retailer in America with a full parking lot every visit, but the PEG ratio sits at 4.0 — four times the growth rate — and my rule is that anything above 2.0 is dangerous territory, especially for a Stalwart where you hope for 30–50% over two to three years. Conviction: Conviction firms up when you match the insider-selling pattern (zero buys, net $2.3M sold in 90 days) with the weekly chart showing no momentum: when the people who know the business best are trimming and the tape confirms a pause, the case for waiting is hard to dispute.

The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed

Signal: Even the bull-case DCF — 10% revenue growth for five years, 6% for the next five, and margin expansion to 4.5% — produces an implied value of roughly $870 per share, still 9% below the market price, meaning the stock is pricing in a level of perfection that leaves no room for error. Conviction: Conviction strengthens because the market-implied scenario requires either a terminal growth rate above 10% or a WACC below 6%, and neither is credible in the current macro environment — the numbers simply do not stretch far enough to meet the market's story.

The Forensic SkepticContrarian/Forensic🔴 BearishMed

Signal: Costco is one of the best businesses in retail, but at 48x earnings with revenue growth decelerating into the 7–10% range, even a modest P/E contraction to 35x would mean a 25% downside — and no catalyst exists to push earnings growth high enough to justify the current multiple. Conviction: The conviction behind the bearish signal comes from the asymmetry: insiders are trimming with zero buys, the weekly MACD is bearish, and the stock is drifting in a high-volume node with no new fundamental thesis — a setup where gravity tends to win, even if the timing is uncertain.

The Activist CatalystActivist/Capital Allocation NeutralMed

Signal: Costco's membership model, ~30% Kirkland mix, and 92%+ renewal rates create one of the most durable retail franchises in the world, but paying 45–48x trailing earnings for a business compounding revenue at 8–10% is not an investment — it is an act of faith with no margin of safety. Conviction: Conviction is held back because the stock sits in a no-edge zone between $970 resistance and $933 support, and until the price moves decisively in either direction — or pulls back to $850–$880 where the forward P/E would compress to roughly 37x — there is simply no reason to commit capital.

Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.

Where they agree — and where they clash

Common ground

  • All six voices rank Costco as an elite business: the membership model, Kirkland Signature brand power, 92%+ renewal rates, and 38% ROIC are undisputed.
  • All six note that the balance sheet is pristine — net cash of $11.76B, interest coverage of 76.9x, and free cash flow that matches net income almost dollar for dollar.
  • None of the six voices recommend buying at the current price of ~$961; even the neutral camp frames their stance as "wait for a pullback," not "hold and hope."
  • Every voice flags the insider-selling pattern — zero buys and net $2.3M in sales over 90 days — as a signal that those closest to the business see limited near-term upside.
  • The technical picture is unanimously read as cautionary: weekly MACD bearish, price below the 20-week EMA, and the stock consolidating between $933 support and $970 resistance.

The real debate

The question it comes down to: Is Costco's durable moat and 8–10% steady growth worth paying 48x trailing earnings when a pullback to the $770–$940 range — a level that has historically attracted institutional accumulation — would materially improve the long-term compounding math, or does waiting risk missing a quality compounder that has rarely traded at a conventional discount?

The bottom line

  • Key support to watch: The $933–$940 zone (monthly EMA20 and Fibonacci 23.6% confluence) is the line in the sand: a weekly close below it on elevated volume would confirm Stage 3 and open a path toward $844.
  • Trigger to confirm the breakout: A weekly close above $970.28 with a positive MACD histogram turn would signal the correction is over and the monthly bull trend is reasserting itself.
  • Next catalyst: Q4 FY2026 earnings in late September 2026 — any guidance disappointment on comparable sales or membership renewals could compress the multiple sharply from 48x given how much good news is already priced in.
  • Number that flips the fundamental debate: If comparable sales growth accelerates above 12% for two consecutive quarters, the bull-case DCF values move above $900 and the growth-story argument gains real traction against the valuation skeptics.
  • Risk to monitor: A membership renewal rate dip below 90% — currently at 92.2% in North America — would signal moat erosion and undercut the core thesis that justifies any premium multiple at all.

contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · No direct position held in COST · COST verdict history → · Methodology →

Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Stay ahead of COST's next verdict

The panel's view can flip on new earnings, a guidance cut, or a valuation shift. Get the update the moment it happens — not weeks later.

One email, only on a verdict change. Unsubscribe anytime.